Deltec Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Deltec Asset Management's XBI Position: Q3 2026 in Review
Deltec Asset Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 36% in Q3 2026, selling an estimated $789K and leaving 9,000 shares worth $1.42M. The position accounts for 0.22% of the portfolio, ranked #63.
Deltec Asset Management first reported a position in XBI in Q1 2017 and has held it in 20 quarters since. The position peaked at $4.99M in Q1 2017. 952 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Deltec Asset Management held 9,000 shares of State Street SPDR S&P Biotech ETF worth $1.42M as of Q3 2026.
- Deltec Asset Management sold 5,000 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $789K.
- State Street SPDR S&P Biotech ETF made up 0.22% of Deltec Asset Management's portfolio in Q3 2026, its #63 holding.
- Deltec Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 20 quarters since.
- Deltec Asset Management's State Street SPDR S&P Biotech ETF position peaked at $4.99M in Q1 2017.
- 952 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Deltec Asset Management's 13F filing for Q3 2026, filed 26 Oct 2026.